Jean‐Jacques Kiladjian

Author

Also Known As

A M Vannucchi, Benjamin L Ebert, Heinz Gisslinger, J J Kiladjian, J Kiladjian, J-J Kiladjian, J. Kiladjian, J.-J. Kiladjian, J.J. Kiladjian, JJ Kiladjian

762

Publications

28.8K

Citations

H-Index

107

Concepts

All Affiliations

Hôpital Saint-Louis Université Paris Cité University of Florence Inserm Assistance Publique – Hôpitaux de Paris

About

Jean‐Jacques Kiladjian is an author at Hôpital Saint-Louis specializing in hematology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	64	5.4K
2	Health Sciences	16	23	1.9K
3	Public Health	2	2	42
4	Engineering	1	1	13
5	Natural Sciences	1	1	40

Jean‐Jacques Kiladjian

205

Publications

20.6K

Citations

H-Index

Page 1

	Year	Citations
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Blood	2022	2.4K
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis Claire Harrison, Jean‐Jacques Kiladjian, Haifa Kathrin Al‐Ali, New England Journal of Medicine	2012	1.8K
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin Nicole Casadevall, J Nataf, B Viron, New England Journal of Medicine	2002	1.2K
Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Martin Grießhammer, New England Journal of Medicine	2015	851
Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet Tiziano Barbui, Giovanni Barosi, Gunnar Birgegård, Journal of Clinical Oncology Mixed-phenotype Acute LeukemiaEuropean LeukemianetPathologyTumor BiologyMyeloid Neoplasia	2011	825
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera Jean‐Jacques Kiladjian, Bruno Cassinat, Sylvie Chevret, Blood	2008	567
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs Robyn M. Emanuel, Amylou C. Dueck, Holly L. Geyer, Journal of Clinical Oncology	2012	441
Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis Francisco Cervantes, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Blood	2013	421
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Peter Hillmen, Jeff Szer, Ilene C. Weitz, New England Journal of Medicine	2021	356
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases Jean‐Jacques Kiladjian, Francisco Cervantes, Frank W.G. Leebeek, Blood	2008	355

Page 1